Avidity Partners Management’s Caribou Biosciences CRBU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,785,352	Closed	-$29.7M	–	90
2024 Q1	$29.7M	Sell	5,785,352 -574,860	-9%	-$3.54M	1.06%	38
2023 Q4	$36.4M	Buy	6,360,212 +310,000	+5%	+$1.53M	1.39%	37
2023 Q3	$28.9M	Buy	6,050,212 +3,291,612	+119%	+$20.4M	1.16%	40
2023 Q2	$11.7M	Hold	2,758,600	–	–	0.41%	70
2023 Q1	$14.6M	Sell	2,758,600 -124,000	-4%	-$772K	0.49%	60
2022 Q4	$18.1M	Sell	2,882,600 -290,000	-9%	-$2.58M	0.42%	54
2022 Q3	$33.5M	Buy	3,172,600 +222,600	+8%	+$2.07M	0.73%	47
2022 Q2	$16M	Buy	2,950,000 +130,933	+5%	+$1M	0.37%	42
2022 Q1	$25.9M	Buy	2,819,067 +145,000	+5%	+$1.53M	0.57%	47
2021 Q4	$40.4M	Buy	2,674,067 +200,000	+8%	+$3.89M	0.86%	39
2021 Q3	$59.1M	Buy	+2,474,067	New	+$60.5M	1.51%	29